Genta Incorporated
Genta Incorporated Announces First Quarter 2009 Financial Results
Published in Gastroenterology Week, May 25th, 2009
Genta Incorporated (OTCBB: GNTA.OB) announced financial results for the quarter ended March 31, 2009. The Company recorded significant milestones in the third quarter, including the following: AGENDA Phase 3 trial of Genasense® in melanoma completes enrollment: Final safety and futility analysis expected May 2009 Progression-free survival (PFS) result expected Q4 2009 Tesetaxel dose-ranging trial opens: Initial data on all dose levels expected at ASCO, June 2009 “The major event of the quarter has been the completion of enrollment into the Phase 3 AGENDA trial in advanced melanoma,” said Dr. Raymond P. Warrell, Jr., Genta’s Chief Executive Officer. “The demographic profile of registered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American Cancer Society
City-dwellers have higher risk of late-stage cancer than rural residents - American Society of Nephrology
Kidney disease patients reap rewards of prevention - BioMed Central
Sodium bicarbonate reduces incidence of contrast-induced nephropathy - Group Health Cooperative Center for Health Studies
Acupuncture eases chronic low back pain in SPINE trial - JAMA and Archives Journals
Diet and exercise intervention helps older, overweight cancer survivors reduce functional decline - University of Montreal
Novel therapy may prove effective in treatment of 30 percent of cancers - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
